Last updated: June 26, 2023
Sponsor: Kathy Grinde
Overall Status: Completed
Phase
N/A
Condition
Limb Spasticity
Cerebral Palsy
Cataplexy
Treatment
Modified constraint induced movement therapy
Standard care for infant with asymmetrical hand function
Neuromuscular electrical stimulation
Clinical Study ID
NCT05134272
infantconstraint2021
Ages 7-10 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Infant is 7-10 months of age (CCA)
- Clinical presentation of asymmetrical hand function,
- Grade 2/5 movement in more impaired upper extremity,
- Demonstrate potential to participate in 6 hours of therapy/week during 3 week episodeof mCIMT-NMES, as determined by principal investigator,
- Parent/guardian willing to be partners in study and participate in follow-upassessments until child is 18 months of age
Exclusion
Exclusion Criteria:
- Medical or sensory condition that prevents full therapy participation (activeseizures, significant visual impairment)
- Received Botox injection to more impaired upper extremity within last 6 months,
- NMES contraindicated (impaired skin integrity, presence of pacemaker, clottingdisorder),
- Previous UE surgery or nerve injury (brachial plexus)
Study Design
Total Participants: 5
Treatment Group(s): 3
Primary Treatment: Modified constraint induced movement therapy
Phase:
Study Start date:
November 17, 2021
Estimated Completion Date:
May 31, 2023
Study Description
Connect with a study center
Children's Minnesota
Maple Grove, Minnesota 55369
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.